Declaratory Statements, Advisory Opinions, & Policy Statements
These statements have been adopted by the Board; the date posted is the date of its approval.
02-17-2022 Laboratory Testing by Pharmacies
11-18-2020 Dispensing Prescriptions for Cannabidiol (Epidiolex®) (rescinded 8-18-2021)
11-13-2019 Administration of Immunizations Without Medical Orders by Pharmacy Interns
11-13-2019 Addition of Flavoring Agents to Prescription Medications
08-14-2019 Reporting Changes in Pharmacy Employment
08-14-2019 Reporting Transactions in Marijuana Pharmacies
08-14-2019 Sale of CBD Oil Products in Marijuana Pharmacies
02-19-2019 Revised Guidance Information re Cannabidiol (CBD) Oil (rescinded 08-14-2019)
02-19-2019 Electronic Prior Authorizations (Rule Interpretation)
11-14-2018 Guidance Information re Cannabidiol (CBD) Oil (revised 02-19-2019)
11-14-2018 Compounding of Drugs by Nurses
11-14-2018 Joint Accreditation of Interprofessional Continuing Education Activity
08-23-2017 Transfer of Prescription Information Between Pharmacies (rescinded 02-21-2024)
02-24-2016 Pharmacies & Independent Marketing Contractors
08-12-2015 Recording Patient Address on Controlled Substance Prescriptions (rescinded 5-26-2021)
08-06-2014 Medication Therapy Management (MTM) in Pharmacy Practice
08-22-2012 Cognitive Services from Consultant Pharmacists Affiliated with Permitted Pharmacy
05-02-2012 Storage of Regulated Materials & Records in Un-Regulated Areas External to Prescription Department
05-05-2010 Dispensing Medications Pursuant to Standing Order During Public Health Emergencies
02-03-2010 Pharmacy Recordkeeping Requirements and Integrated Electronic Medical Record Systems
11-18-2009 Moderately Complex Laboraory Tests (rescinded 2-17-2022)